181 results on '"Varaldo, R"'
Search Results
2. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome
3. DLI after haploidentical BMT with post-transplant CY
4. Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin’s lymphoma
5. Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update
6. DISCONTINUING IMMUNOSUPPRESSIVE THERAPY FOLLOWING AN ALLOGENEIC HEMOPOIETIC STEM CELL TRANSPLANT (HSCT):A CROSS SECTIONAL ANALYSIS OF 799 PATIENTS, 1 YEAR POST TRANSPLANT: PH-P337
7. UNMANIPULATED HAPLOIDENTICAL TRANSPLANTS FOR ACUTE MYELOID LEUKEMIA (AML) AND REFRACTORY ANEMIA WITH EXCESS BLASTS (RAEB): PH-O126
8. PRE-ENGRAFTMENT BLOODSTREAM INFECTIONS IN 489 HAEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: AETIOLOGY, RISK FACTORS AND IMPACT ON MORTALITY.: PH-O023
9. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts: a single Center experience in 488 patients: O383
10. Anti-CD26 monoclonal antibody for the treatment of steroidrefractory acute graft-versus-host disease (SR-GvHD): a report of two prospective studies: O159
11. Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse
12. Risk factors for non-relapse mortality in 287 patients receiving 1288 donor lymphocyte infusions: P1046
13. Post-transplant CMV reactivation after CBT: the role of delayed immune reconstitution or donorʼs seronegativity?: P756
14. Intra-bone cord blood transplant is associated with reconstitution of haematopoietic stem cell reservoir in adult patients: P523
15. Myeloablative transplants from unrelated donors: intra-bone cord blood compared to adult unrelated donor; a single-centre experience: O408
16. Acute graft-versus-host disease II-IV in 1465 patients: has outcome improved over the past two decades?: O386
17. Aggressive multiple sclerosis: a single‐centre, real‐world treatment experience with autologous haematopoietic stem cell transplantation and alemtuzumab
18. Intrabone marrow transplantation of cord blood cells is associated with better platelet recovery and decreased acute GvHD as compared with intravenous transplantation: an EUROCORD matched-paired analysis: O106
19. S1624 A DAY 100 LAB-SCORE PREDICTS EXTENSIVE CGVHD, OVERALL SURVIVAL AND TRANSPLANT-RELATED MORTALITY AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION: FINAL ANALYSIS
20. PF780 STEM CELL TRANSPLANTATION FOR ACQUIRED APLASTIC ANEMIA: THE ROLE OF THE CONDITIONING REGIMEN
21. Visceral leishmaniasis in hematopoietic cell transplantation: Case report and review of the literature
22. La complessità della New Economy: Tecnologia e Organizzazione
23. Percorsi di innovazione nei modelli di business
24. DLI after haploidentical BMT with post-transplant CY
25. I rapporti con il mercato delle medie imprese italiane: risultati di una case study research
26. Un tesoro emergente. Le medie imprese italiane dell'era globale
27. Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up (on behalf of the GIMEMA Working Party on Chronic Myeloid Leukemia)
28. Chronicmyeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of thepatients alive after a 6-year follow-up
29. TREATMENT OF PHILADELPHIA-POSITIVE CHRONIC MYELOID LEUKEMIA WITH IMATINIB: THE IMPORTANCE OF A STABLE MOLECULAR RESPONSE
30. Marketing-non-marketing all’italiana. Virtù, limiti e prospettive
31. Chemoimmunotherapy with low dose vinorelbine and interleukin-2 in treatment of patients with metastatic renal cell carcinoma
32. La società italiana di marketing al passaggio del suo primo triennio di vita
33. PEG-Intron in essential thrombocythaemia: two years treatment evaluation
34. Pharmacologic characteristics and clinical activity of human rituximab anti-C monoclonal antibody
35. Quality of life and brain function during high dose recombinant human erythropoietin treatment in low-risk myelodysplastic syndromes
36. PEG Intron in essential thrombocythemai: two years tretament in 90 patients
37. Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin’s lymphoma
38. Peg Interferon a- 2b (Peg Intron) in essential Thrombocythemia
39. Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse
40. Lymphoplasmacytic lymphoma/immunocytoma: towards a disease-targeted treatment?
41. Thalidomide in agnogenic and secondary myelofibrosis
42. Cambiamenti istituzionali nell'impresa distrettuale: meccanismi inerziali e logiche di evoluzione
43. Lineapiù: oltre le frontiere imprenditoriali del distretto
44. THE EVOLUTIONARY NATURA OF THE FIRMS WITHIN INDUSTRIAL DISTRICTS
45. L’industrialismo nel pensiero di Antonio Renzi
46. Franchising e internazionalizzazione delle imprese
47. La natura e la dinamica dell'impresa distrettuale
48. Late Platelets Recovery after Autografting (ASCT) in Patients with Acute Myeloid Leukemia (AML) Is A Prognostically Favourable Factor for Long-Term Remission
49. Reduced-Intensity Conditioning for Allograft (RICT) after Cytoreductive Autograft (ASCT) in Relapsed/Resistant Hodgkin’s Lymphoma (HL)
50. PO023 High dose of r-EPO (40,000 IU) once a week is highly effective in a selected cohort of MDS patients with basal EPO level
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.